Inspire Investing’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$802K Buy
2,731
+286
+12% +$81.1K 0.03% 457
2026
Q1
$682K Buy
2,445
+1,362
+126% +$392K 0.04% 387
2025
Q4
$328K Sell
1,083
-55
-5% -$17.2K 0.03% 758
2025
Q3
$319K Sell
1,138
-22
-2% -$5.99K 0.03% 743
2025
Q2
$280K Sell
1,160
-121
-9% -$28.6K 0.03% 785
2025
Q1
$312K Buy
1,281
+492
+62% +$148K 0.04% 767
2024
Q4
$259K Sell
789
-71
-8% -$24.1K 0.03% 779
2024
Q3
$288K Sell
860
-104
-11% -$33K 0.03% 765
2024
Q2
$263K Sell
964
-310
-24% -$90.2K 0.03% 779
2024
Q1
$441K Sell
1,274
-100
-7% -$32.9K 0.05% 351
2023
Q4
$444K Buy
1,374
+362
+36% +$113K 0.05% 339
2023
Q3
$363K Sell
1,012
-32
-3% -$12.3K 0.05% 351
2023
Q2
$396K Buy
1,044
+256
+32% +$104K 0.05% 322
2023
Q1
$377K Sell
788
-27
-3% -$12.6K 0.05% 296
2022
Q4
$343K Buy
815
+114
+16% +$46K 0.04% 275
2022
Q3
$292K Buy
701
+85
+14% +$42.4K 0.04% 258
2022
Q2
$305K Sell
616
-10
-2% -$5.21K 0.04% 264
2022
Q1
$353K Buy
626
+197
+46% +$119K 0.04% 304
2021
Q4
$324K Buy
429
+3
+0.7% +$2.25K 0.04% 292
2021
Q3
$318K Buy
+426
New +$319K 0.04% 311

Other funds holding BIO

Inspire Investing's BIO Position: Q2 2026 in Review

Inspire Investing increased its Bio-Rad Laboratories Class A (BIO) stake by 12% in Q2 2026, buying an estimated $81.1K and bringing the position to 2,731 shares worth $802K. The position accounts for 0.03% of the portfolio, ranked #457.

Inspire Investing first reported a position in BIO in Q3 2021 and has held it in 20 quarters since. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Inspire Investing held 2,731 shares of Bio-Rad Laboratories Class A worth $802K as of Q2 2026.
  • Inspire Investing bought 286 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $81.1K.
  • Bio-Rad Laboratories Class A made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #457 holding.
  • Inspire Investing first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and has held it in 20 quarters since.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.